These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

802 related articles for article (PubMed ID: 29682542)

  • 21. The Effect of Probiotics on Gut Microbiota during the Helicobacter pylori Eradication: Randomized Controlled Trial.
    Oh B; Kim BS; Kim JW; Kim JS; Koh SJ; Kim BG; Lee KL; Chun J
    Helicobacter; 2016 Jun; 21(3):165-74. PubMed ID: 26395781
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Probiotics, prebiotics and colorectal cancer prevention.
    Ambalam P; Raman M; Purama RK; Doble M
    Best Pract Res Clin Gastroenterol; 2016 Feb; 30(1):119-31. PubMed ID: 27048903
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gut microbiome approaches to treat obesity in humans.
    Bianchi F; Duque ALRF; Saad SMI; Sivieri K
    Appl Microbiol Biotechnol; 2019 Feb; 103(3):1081-1094. PubMed ID: 30554391
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intestinal microbiota in liver disease.
    Haque TR; Barritt AS
    Best Pract Res Clin Gastroenterol; 2016 Feb; 30(1):133-42. PubMed ID: 27048904
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gut microbiota biomodulators, when the stork comes by the scalpel.
    Miniello VL; Colasanto A; Cristofori F; Diaferio L; Ficele L; Lieggi MS; Santoiemma V; Francavilla R
    Clin Chim Acta; 2015 Dec; 451(Pt A):88-96. PubMed ID: 25668229
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Strategies to increase the efficacy of using gut microbiota for the modulation of obesity.
    Li J; Riaz Rajoka MS; Shao D; Jiang C; Jin M; Huang Q; Yang H; Shi J
    Obes Rev; 2017 Nov; 18(11):1260-1271. PubMed ID: 28742949
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Gut microbiota and immune crosstalk in metabolic disease].
    Burcelin R
    Biol Aujourdhui; 2017; 211(1):1-18. PubMed ID: 28682223
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Gut Microbiota and Ageing.
    Maynard C; Weinkove D
    Subcell Biochem; 2018; 90():351-371. PubMed ID: 30779015
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gut microbiota and chronic kidney disease: implications for novel mechanistic insights and therapeutic strategies.
    Pan W; Kang Y
    Int Urol Nephrol; 2018 Feb; 50(2):289-299. PubMed ID: 28849345
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gut microbiota and renal transplant outcome.
    Ardalan M; Vahed SZ
    Biomed Pharmacother; 2017 Jun; 90():229-236. PubMed ID: 28363168
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gut microbiota and malnutrition.
    Million M; Diallo A; Raoult D
    Microb Pathog; 2017 May; 106():127-138. PubMed ID: 26853753
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeting gut microbiota as a possible therapy for diabetes.
    He C; Shan Y; Song W
    Nutr Res; 2015 May; 35(5):361-7. PubMed ID: 25818484
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of the modulation of microbiota on the gastrointestinal immune system and bowel function.
    Kanauchi O; Andoh A; Mitsuyama K
    J Agric Food Chem; 2013 Oct; 61(42):9977-83. PubMed ID: 24070265
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gut microbiota and allogeneic transplantation.
    Wang W; Xu S; Ren Z; Jiang J; Zheng S
    J Transl Med; 2015 Aug; 13():275. PubMed ID: 26298517
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Therapeutic Opportunities in Intestinal Microbiota-Virus Interactions.
    Monedero V; Collado MC; Rodríguez-Díaz J
    Trends Biotechnol; 2018 Jul; 36(7):645-648. PubMed ID: 29395344
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of galacto-oligosaccharide mixture (B-GOS) on gut microbiota, immune parameters and metabonomics in elderly persons.
    Vulevic J; Juric A; Walton GE; Claus SP; Tzortzis G; Toward RE; Gibson GR
    Br J Nutr; 2015 Aug; 114(4):586-95. PubMed ID: 26218845
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Microbiota-Gut-Brain Axis in Neuropsychiatric Disorders: Pathophysiological Mechanisms and Novel Treatments.
    Kim YK; Shin C
    Curr Neuropharmacol; 2018; 16(5):559-573. PubMed ID: 28925886
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Microbiome Disturbances and Autism Spectrum Disorders.
    Rosenfeld CS
    Drug Metab Dispos; 2015 Oct; 43(10):1557-71. PubMed ID: 25852213
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The gut microbiota: A treasure for human health.
    Li D; Wang P; Wang P; Hu X; Chen F
    Biotechnol Adv; 2016 Nov; 34(7):1210-1224. PubMed ID: 27592384
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antibiotic administration and the development of obesity in children.
    Principi N; Esposito S
    Int J Antimicrob Agents; 2016 Mar; 47(3):171-7. PubMed ID: 26895606
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 41.